--2024/Q4-- / 3.150M--
--2024/Q3-- / 2.625M--
Aug 13, 20242024/Q22.400M / 3.155M--
May 9, 20242024/Q12.631M / 3.280M--
Mar 26, 20242023/Q43.727M / 3.400M--
US Stock MarketDetailed Quotes
NBY NovaBay Pharmaceuticals
- 0.7160
- -0.0364-4.84%
Close Oct 31 16:00 ET
- 0.7321
- +0.0161+2.25%
Post 18:44 ET
3.50MMarket Cap-10P/E (TTM)
0.7600High0.6950Low313.18KVolume0.7600Open0.7524Pre Close227.00KTurnover6.42%Turnover RatioLossP/E (Static)4.89MShares12.775052wk High-5.59P/B3.49MFloat Cap0.361152wk Low--Dividend TTM4.88MShs Float130156.1979Historical High--Div YieldTTM8.64%Amplitude0.3610Historical Low0.7240Avg Price1Lot Size
NovaBay Pharmaceuticals Key Stats
NovaBay Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
NovaBay Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
